Kevin Koch - Net Worth and Insider Trading
Kevin Koch Net Worth
The estimated net worth of Kevin Koch is at least $27 Million dollars as of 2025-04-29. Kevin Koch is the President & CSO of Array BioPharma Inc and owns about 555,354 shares of Array BioPharma Inc (ARRY) stock worth over $22 Million. Kevin Koch is also the President and CEO of Edgewise Therapeutics Inc and owns about 353,262 shares of Edgewise Therapeutics Inc (EWTX) stock worth over $6 Million. Details can be seen in Kevin Koch's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kevin Koch has not made any transactions after 2025-03-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kevin Koch
Kevin Koch Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kevin Koch owns 2 companies in total, including Viridian Therapeutics Inc (VRDN) , and Edgewise Therapeutics Inc (EWTX) .
Click here to see the complete history of Kevin Koch’s form 4 insider trades.
Insider Ownership Summary of Kevin Koch
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| VRDN | Viridian Therapeutics Inc | 2017-02-13 | director |
| EWTX | Edgewise Therapeutics Inc | 2025-03-07 | director & President and CEO |
Kevin Koch Latest Holdings Summary
Kevin Koch currently owns a total of 2 stocks. Among these stocks, Kevin Koch owns 555,354 shares of Array BioPharma Inc (ARRY) as of February 5, 2007, with a value of $22 Million and a weighting of 79.61%. Kevin Koch also owns 353,262 shares of Edgewise Therapeutics Inc (EWTX) as of March 7, 2025, with a value of $6 Million and a weighting of 20.39%.
Latest Holdings of Kevin Koch
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARRY | Array BioPharma Inc | 2007-02-05 | 555,354 | 38.95 | 21,631,038 |
| EWTX | Edgewise Therapeutics Inc | 2025-03-07 | 353,262 | 15.68 | 5,539,148 |
Holding Weightings of Kevin Koch
Kevin Koch Form 4 Trading Tracker
According to the SEC Form 4 filings, Kevin Koch has made a total of 0 transactions in Array BioPharma Inc (ARRY) over the past 5 years. The most-recent trade in Array BioPharma Inc is the sale of 20,000 shares on February 5, 2007, which brought Kevin Koch around $281,000.
According to the SEC Form 4 filings, Kevin Koch has made a total of 4 transactions in Edgewise Therapeutics Inc (EWTX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Edgewise Therapeutics Inc is the sale of 100 shares on March 7, 2025, which brought Kevin Koch around $3,000.
Insider Trading History of Kevin Koch
- 1
Kevin Koch Trading Performance
Kevin Koch Ownership Network
Ownership Network List of Kevin Koch
Ownership Network Relation of Kevin Koch
Kevin Koch Owned Company Details
What does Viridian Therapeutics Inc do?
Who are the key executives at Viridian Therapeutics Inc?
Kevin Koch is the director of Viridian Therapeutics Inc. Other key executives at Viridian Therapeutics Inc include director & President and CEO Stephen F. Mahoney , Chief Operating Officer Thomas W. Beetham , and director & other: See Remarks Fairmount Healthcare Fund Ii Gp Llc .
Viridian Therapeutics Inc (VRDN) Insider Trades Summary
Over the past 18 months, Kevin Koch made no insider transaction in Viridian Therapeutics Inc (VRDN). Other recent insider transactions involving Viridian Therapeutics Inc (VRDN) include a net purchase of 1,600,000 shares made by Fairmount Healthcare Fund Ii Gp Llc , a net purchase of 476,190 shares made by Fairmount Healthcare Fund Gp Llc , and a net purchase of 21,400 shares made by Stephen F. Mahoney .
In summary, during the past 3 months, insiders sold 0 shares of Viridian Therapeutics Inc (VRDN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Viridian Therapeutics Inc (VRDN) were sold and 2,102,590 shares were bought by its insiders, resulting in a net purchase of 2,102,590 shares.
Viridian Therapeutics Inc (VRDN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Viridian Therapeutics Inc Insider Transactions
Kevin Koch Mailing Address
Above is the net worth, insider trading, and ownership report for Kevin Koch. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Kevin Koch's mailing address is: Boulder Co 80301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
